KPIs & Operating Metrics(New)
Growth Metrics

Charles River Laboratories International (CRL) Non-Current Deferred Tax Liability (2016 - 2025)

Charles River Laboratories International (CRL) has 15 years of Non-Current Deferred Tax Liability data on record, last reported at $95.2 million in Q4 2025.

  • For Q4 2025, Non-Current Deferred Tax Liability fell 10.99% year-over-year to $95.2 million; the TTM value through Dec 2025 reached $95.2 million, down 10.99%, while the annual FY2025 figure was $95.2 million, 10.99% down from the prior year.
  • Non-Current Deferred Tax Liability reached $95.2 million in Q4 2025 per CRL's latest filing, down from $123.0 million in the prior quarter.
  • Across five years, Non-Current Deferred Tax Liability topped out at $420.6 million in Q4 2021 and bottomed at $95.2 million in Q4 2025.
  • Average Non-Current Deferred Tax Liability over 5 years is $193.6 million, with a median of $193.7 million recorded in 2022.
  • Peak YoY movement for Non-Current Deferred Tax Liability: skyrocketed 93.79% in 2021, then tumbled 48.74% in 2022.
  • A 5-year view of Non-Current Deferred Tax Liability shows it stood at $420.6 million in 2021, then crashed by 48.74% to $215.6 million in 2022, then fell by 11.24% to $191.3 million in 2023, then crashed by 44.1% to $107.0 million in 2024, then decreased by 10.99% to $95.2 million in 2025.
  • Per Business Quant database, its latest 3 readings for Non-Current Deferred Tax Liability were $95.2 million in Q4 2025, $123.0 million in Q3 2025, and $109.3 million in Q2 2025.